HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory A Wiseman Selected Research

Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)

4/201718F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma.
7/201018F-FDG PET and PET/CT in Burkitt's lymphoma.
7/200818F-FDG PET in the management of patients with anaplastic thyroid carcinoma.
4/2008The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.
11/200718F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
5/2007The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
7/2005Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory A Wiseman Research Topics

Disease

19Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2013 - 02/2002
11Neoplasms (Cancer)
07/2018 - 02/2002
5Lymphoma (Lymphomas)
01/2017 - 08/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 04/2003
3Hepatocellular Carcinoma (Hepatoma)
07/2020 - 11/2009
3Thyroid Neoplasms (Thyroid Cancer)
04/2011 - 04/2002
3Pain (Aches)
06/2010 - 01/2002
3Neoplasm Metastasis (Metastasis)
10/2005 - 01/2002
3Thrombocytopenia (Thrombopenia)
04/2003 - 06/2002
2Melanoma (Melanoma, Malignant)
07/2018 - 04/2017
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 09/2014
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2017 - 10/2011
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2017 - 06/2002
2Osteosarcoma (Osteogenic Sarcoma)
10/2005 - 01/2002
2Pancytopenia
10/2005 - 09/2002
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017
1Second Primary Neoplasms (Neoplasms, Second)
09/2014
1Infections
09/2014
1Prostatic Neoplasms (Prostate Cancer)
01/2012
1Carcinoid Tumor (Carcinoid)
08/2010
1Burkitt Lymphoma (Burkitt's Lymphoma)
07/2010
1Multiple Myeloma
06/2010
1Autoimmune Hepatitis
11/2009
1Thrombosis (Thrombus)
11/2009
1Pheochromocytoma
09/2009
1Paraganglioma (Paragangliomas)
09/2009
1Anaplastic Thyroid Carcinoma
07/2008
1T-Cell Lymphoma (Lymphoma, T Cell)
04/2008
1Renal Cell Carcinoma (Grawitz Tumor)
08/2007
1Hypothyroidism
06/2007
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
06/2007
1Thyroiditis
06/2007
1Thyroid Nodule (Nodule, Thyroid)
05/2007
1Pathologic Complete Response
08/2006
1Adenoma (Adenomas)
03/2006
1Hyperplasia
03/2006
1Mucositis
10/2005
1Ewing Sarcoma (Sarcoma, Ewing)
02/2005
1Disease Progression
09/2002
1Fever (Fevers)
09/2002
1Hypocalcemia
01/2002

Drug/Important Bio-Agent (IBA)

13ibritumomab tiuxetan (Zevalin)FDA Link
07/2013 - 02/2002
7Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2017 - 07/2005
5Yttrium-90IBA
07/2020 - 09/2002
5YttriumIBA
07/2013 - 04/2006
5Rituximab (Mabthera)FDA Link
10/2011 - 02/2002
4RadiopharmaceuticalsIBA
06/2010 - 01/2002
4Monoclonal AntibodiesIBA
08/2007 - 02/2002
3Glucose (Dextrose)FDA LinkGeneric
09/2014 - 07/2010
2IodineIBA
01/2012 - 04/2002
2samarium Sm-153 lexidronam (Quadramet)FDA Link
06/2010 - 10/2005
2Melphalan (Alkeran)FDA LinkGeneric
06/2010 - 02/2005
2Radioisotopes (Radionuclides)IBA
11/2009 - 01/2002
2SamariumIBA
08/2006 - 10/2005
2Pharmaceutical PreparationsIBA
04/2003 - 09/2002
1GlucocorticoidsIBA
01/2021
1Immune Checkpoint InhibitorsIBA
07/2018
1pembrolizumabIBA
07/2018
1IpilimumabIBA
07/2018
1Interleukin-2 (IL2)IBA
07/2018
1ibrutinibIBA
01/2017
1LigandsIBA
01/2017
1ProMune (CpG 7909)IBA
07/2013
1OligodeoxyribonucleotidesIBA
07/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2011
1Vincristine (Oncovin)FDA LinkGeneric
10/2011
1epratuzumabIBA
10/2011
1Prednisone (Sone)FDA LinkGeneric
10/2011
1anti-thyroglobulinIBA
04/2011
1AutoantibodiesIBA
04/2011
1Somatostatin Receptors (Somatostatin Receptor)IBA
08/2010
1Therapeutic UsesIBA
01/2010
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
11/2009
1SteroidsIBA
11/2009
1CatecholaminesIBA
09/2009
1MetanephrineIBA
09/2009
1AntigensIBA
08/2007
1Thyroxine (Levothyroxine)FDA LinkGeneric
06/2007
1AntibodiesIBA
06/2007
1Thyroid HormonesIBA
06/2007
1CD20 AntigensIBA
04/2006
1GemcitabineFDA Link
10/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2002
1Biological ProductsIBA
05/2002
1Samarium-153IBA
01/2002
1ethyleneIBA
01/2002
1Organophosphonates (Phosphonates)IBA
01/2002
1Opiate AlkaloidsIBA
01/2002
1DiaminesIBA
01/2002

Therapy/Procedure

15Radioimmunotherapy
01/2017 - 02/2002
14Therapeutics
01/2022 - 04/2002
7Drug Therapy (Chemotherapy)
01/2017 - 06/2002
2Immunotherapy
07/2018 - 05/2002
2Radiotherapy
04/2017 - 07/2006
2Transplantation
08/2006 - 09/2002
1Microspheres (Microsphere)
11/2009
1Hematopoietic Stem Cell Transplantation
08/2006
1Aftercare (After-Treatment)
04/2003